Bovine Colostrum Gains Popularity as Immune-Boosting Supplement, Though Evidence Remains Limited
Bovine colostrum, the initial milk produced by mammals after birth, has become an increasingly popular supplement marketed for immune health, gut function, and athletic recovery. The supplement market for immune health has grown significantly since the COVID-19 pandemic, with colostrum now available over-the-counter in powder and pill forms, though it remains unregulated by the FDA. Medical experts say early research shows promise for specific uses like acute diarrhea and respiratory infections, but caution that more rigorous studies are needed before making broad health claims.
Bovine colostrum, derived from cow's milk and rich in antibodies, proteins, and minerals, has emerged as a trending supplement in the broader immune health market, which exceeded $55 billion globally in 2020. The supplement is marketed to address multiple health concerns including immune function, gastrointestinal distress, inflammation, and muscle recovery, and is used by both professional athletes and general consumers. Medical professionals quoted in the article, including physicians from Mayo Clinic and Cleveland Clinic, acknowledge some promising research—particularly regarding acute diarrhea prevention and seasonal respiratory infections—but emphasize that studies remain limited and early-stage. Experts advise consulting healthcare providers before use, particularly for those with dairy allergies or lactose intolerance, and caution against overstating colostrum's benefits until more comprehensive research is available. The lack of FDA regulation means formulations vary significantly between brands.
What's missing
The article does not provide specific details on the quality or sample sizes of the studies cited as showing promise, nor does it discuss potential mechanisms of action beyond intestinal barrier function. Additionally, while the article mentions a 2017 Polish study on zonulin levels, it does not address whether these biochemical changes translate to clinically meaningful health outcomes for users.
What different sources said
- FortuneCenter
Is colostrum a new superfood? Experts explain its immune-boosting benefits
Related
Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction
Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.
Australia's TGA to crack down on illegal peptides; government allocates $100m for arthritis research
Australia's Therapeutic Goods Administration has announced a crackdown on illegal peptides due to a surge in imports and online advertising, designating them a priority focus area. The federal government has simultaneously committed $100 million to medical research into arthritis prevention, diagnosis, and treatment. These developments reflect growing regulatory concerns about unregulated drugs and increased investment in chronic disease research.
GLP-1 Drugs Like Ozempic May Help ADHD Symptoms, According to Patient Reports and Clinical Observations
Social media users and some patients are reporting that GLP-1 receptor agonist drugs like Ozempic appear to improve ADHD symptoms, including increased focus, reduced procrastination, and better impulse control. GLP-1s were originally developed to treat Type 2 diabetes but are being studied for various other conditions. While anecdotal reports are growing, no formal clinical trials are currently testing these drugs specifically for ADHD, and the mechanism behind any potential benefit remains unclear.